About Operations Utopia: Striving for Practical Excellence in Life Sciences Operations
In what may be one of the most niche topics for a podcast, Operations Utopia is a podcast about the desperate need to streamline Life Sciences Operations to get treatments to patients faster and explores how life sciences organizations should operate—by examining why they usually don’t.
Disclaimer: The podcast content represents the opinion of the speakers, guests & host and does not reflect those of their organizations, system vendors, or service providers.
John Jones has been building the same regulatory data platform since the late '90s. The databases changed. The data model didn't. In this episode he explains why companies burn 18 months on plumbing before they ever get to governance, data quality, or compliance, and why he turned the DIA RIM Reference Model into a pre-built platform called Nidura so nobody has to do it again. Matt and John get into why canonical models get a bad name, why AI trips over the same things people trip over, what a real path to taking the human out of the loop looks like, and a side quest on tokens, gym memberships, and pickleball.
30 Sept 2026
11 | Building the Computational Engine Behind Regulatory Planning - with Megha Sinha
Megha Sinha spent close to two decades billing life sciences companies for regulatory planning work — then built software to put that business out of business. In this episode, Matt talks with the founder and CEO of Kolter AI about why she treats regulatory planning as a computation problem rather than an LLM problem, how the platform's architecture evolved after an early PDF-and-RAG approach didn't hold up, the trust model that decides when an AI agent gets to recommend versus decide, and what's left to compete on once an entire industry can run the same planning engine.
15 Sept 2026
10 | The Art and Science of Operations - with Leslie LaCosta
Leslie LaCosta spent 31 years in retail — starting on a sales floor at 15 and becoming a store manager at 18 — before building the Project Management Office at Bed Bath & Beyond and later leading store operations and CX at Party City. In this episode, she and Matt trace a straight line between retail operations and regulated life sciences operations: both live and die on the same thing — getting people to actually do the process, not just agree with it in a meeting. Leslie talks about why transformation initiatives fail when they're stacked on top of someone's existing job, why she built her post-corporate career as a fractional operator ("I'm here for a good time, not a long time"), and why she thinks AI's real value isn't replacing the operator — it's clearing out the "science" so the "art" of operations can actually show up.
28 Aug 2026
09 | The Wait Is Optional - with Frank Nogueira
Manufacturing changes take three to five years to work through the world's regulators today. Companies handle that by maintaining parallel manufacturing lines, delaying changes, or accepting country-level product shortages. That is the default. That is the water we all swim in. Frank Nogueira has spent five years proving that number is a choice, not a law of physics.
Frank is CEO of Accumulus Technologies, the commercial spinout of the nonprofit Accumulus Synergy that ten of the largest biopharma companies formed in 2020. The platform is live across 70+ national regulatory authorities. Submissions can move to multiple regulators in parallel, in real time, with every regulator seeing the same evidence at the same moment. Countries with years of backlog are landing, in Frank's words, on "there's nothing for us to wait three years for."
In this episode, Frank walks Matt through what Accumulus makes possible and why the industry hasn't fully claimed it yet. His frame for the last thirty years: the internet connected people, cloud connected enterprises, AI is connecting knowledge, and the missing layer is connected scientific evidence. His diagnosis of where we sit: "data rich but information poor." His conclusion: technology is no longer the bottleneck. Change management is. Which means the wait for a globally connected regulatory system isn't a technology problem — it's a decision the industry can make.
14 Aug 2026
08 | Beyond the Paperwork — Operational Integrity, CSA, and the Illusion of Validation with Jeff Sovis
Jeff Sovis and Matt push on a tension anyone who has ever run a validation project has felt: the documents say the system is fit for use, but the actual issues never showed up in the documents. This episode is about that gap. Jeff frames it as operational drift — the slow separation between what the paperwork claims and what the organization is actually doing. The conversation moves through GAMP Category 3 SaaS validation and the checkbox trap, into the on-prem → SaaS → AI paradigm collision, and lands on what "human in the loop" actually has to mean when a third, unknown entity is making decisions inside the process. Practical throughout — not a theory episode.
17 Jul 2026
07 | Data Is Not an Afterthought: The RIM Reference Model — with Bala Balasubramanian
Twenty years ago, Bala Balasubramanian was flying around the world for a big-pharma sponsor trying to gather seven basic pieces of information about the company's own products. Generic name. Trade name. Dosage form. Strength. Country. Status. Approval date. It couldn't be done at scale. He told leadership so at the time — and since then, he's spent nearly two decades trying to build the thing that would make it possible.
Bala is the subteam lead for the DIA RIM Reference Model — now in Version 2.0 — and one of the industry's clearest voices on why regulatory operations still treats data as an afterthought, and what it will finally take to change that. Matt Neal sits down with him to trace the arc from a single unusable Excel workbook to a real conceptual data model, why the discipline problem has never been a systems problem, and what changes when data starts being treated the way finance and clinical already treat it: as core to the job, not adjacent to it.
3 Jul 2026
06 | Vibe Coding the Perfect Workflow: Building Systems That Fit Like a Glove — with Paul Slater
Something meaningfully different has happened in the last few weeks — and Paul Slater is one of the few people talking about it in a way that goes past the hype. Paul is a two-decade Microsoft veteran (where he defined the company's Life Sciences strategy), current Adobe thought leader, author of The AI-Ready Human, and host of the Humanity Working podcast. When he says he just built a hybrid CRM / CMS / news feed for his own job in twelve hours using Claude Code, it isn't a party trick. It's a signal.
Matt and Paul spend an hour on what that signal means. The new frontier isn't asking Claude for help; it's vibe coding the perfect workflow for whatever job you have. They get into why every commercial product is an artifact of cost to market, not necessity — and why the product becomes the problem. What survives from the standard-software stack in regulated industries. Why companies like Veeva and Salesforce may need to reinvent themselves as role-enablement layers. And the reason for both Paul's morning "we're all screwed" moments and his afternoon "this is enormous work" ones: almost nothing about how we structure work is fit for purpose.
19 Jun 2026
05 | Trust Architecture: Rethinking Validation for a Probabilistic World — with Nuno Valério
Nuno Valério is Head of Innovation, R&D Quality at Merck, based in Germany. With 11+ years in pharma quality across deviations, audits, and observations, plus an active public-facing practice on AI governance, Nuno has become a distinctive voice on what trustworthy AI looks like inside a regulated R&D organization.
He writes and speaks regularly on a framework he calls trust architecture — a multi-dimensional approach to validating not the model itself but the workflow, guardrails, and human-machine ecosystem around it. He's a featured speaker at the 2026 Clinical Trial Innovation Summit in Basel, where his session focuses on designing AI governance from both sides of the wall — pharma and regulator — drawing on his hands-on work at Merck.
12 Jun 2026
04 | From Alexa to Agents: Two Decades of Change in RegOps — with Scott Cleve
Few people have lived through more change cycles in regulatory operations than Scott Cleve. Across 20+ years at Accenture, AbbVie, Astellas, Boehringer Ingelheim, bluebird bio, and now Daiichi Sankyo, Scott has built and led global Reg Ops organizations through wave after wave of new technology — and figured out a few things about how change actually sticks.
Matt and Scott trace the arc from a 2017 Alexa pilot at Boehringer Ingelheim (RIP — voice capture for affiliate correspondence) to today's reality of AI agents working alongside humans as teammates. Along the way: the three obstacles that quietly slow every change initiative, why "training" a workforce two weeks before go-live with a PowerPoint is the corporate equivalent of asking a kid to play in the World Cup, and the backhanded compliment that defines a great Reg Ops team — you guys do your job so well, I don't even think about it.
29 May 2026
03 | Rethinking the Fence: Data, Standards, and the New Energy in Regulatory — with Crystal Allard
For the first time in a long while, regulatory innovation in life sciences feels less like stasis and more like movement. In this episode of Operations Utopia, Matt Neal sits down with Crystal Allard — a 15-year veteran of the FDA, now leading government strategy at Veeva Systems — for a wide-ranging conversation about why the last year or two feel genuinely different.
The throughline is inevitability. External forces — new leadership at standards bodies like CDISC and HL7, the hard lessons of COVID-era rolling reviews, a generation of digitally-native reviewers, and AI itself — are pushing health authorities toward modern, data-centric, API-driven approaches faster than anyone expected. Along the way, Crystal and Matt get into the parts of the system that still don't work: format rules built for review software rather than reviewers, a submission "fence" that may need rethinking entirely, and the quiet truth that hard-won regulatory knowledge is now being handed to AI whether the industry is ready or not.
15 May 2026
02 | Validation Reimagined: From Paper Binders to Agentic AI, with Bryan Ennis
Matt & Bryan talk Modern Computer System Validation.
24 Apr 2026
01 | Why Biopharma Operating Models Collapse Under Scale
Why Biopharma Operating Models Collapse Under Scale:
What regulatory operations and R&D platforms reveal about how organizations actually function.
The Fireside Chat with Frits Stulp from at the Implement Consulting Group's Veeva Consortium in November 2025.
Reach and audience
Public platform figures. Ratings count people who left a rating, not total listeners.
Spotify
5.0 / 5
1 ratings
Contact Operations Utopia: Striving for Practical Excellence in Life Sciences Operations
Guest appearances
Books guests
Based on episode analysis; this does not confirm that the show is currently accepting guests.
Host of Operations Utopia: Striving for Practical Excellence in Life Sciences Operations?
Claim your podcast to manage its listing and keep your show details accurate.
Pod Engine is an independent podcast discovery and analytics service and is not affiliated with or endorsed by this podcast. Artwork and show content belong to their owners. Full legal notice.
Explore this show Podcast research with Pod Engine
